Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nesiritide: past, present, and future.

A J Burger1, M R Burger

  • 1Division of Cardiology, Beth Israel Deaconess Medical Center, Noninvasive Cardiology Laboratory, Harvard Medical School, Boston, MA 02215, USA. aburger@caregroup.harvard.edu

Minerva Cardioangiologica
|December 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

195Pt NMR and DFT computational methods as tools towards the understanding of speciation and hydration/solvation of [PtX6]2- (X = Cl-, Br-) anions in solution.

Dalton transactions (Cambridge, England : 2003)·2006
Same author

Diabetes and the occurrence of ventricular arrhythmic events in patients with severe left ventricular dysfunction.

Diabetologia·2002
Same author

Role of endothelin in modulation of heart rate variability in patients with decompensated heart failure.

Pacing and clinical electrophysiology : PACE·2002
Same author

BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential.

Current opinion in investigational drugs (London, England : 2000)·2002
Same author

Blunted sympathetic response in diabetic patients with decompensated congestive heart failure.

International journal of cardiology·2001
Same author

Diabetic autonomic neuropathy: the clinical interpretation of improved technology.

Diabetes technology & therapeutics·2001
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Nesiritide, a synthetic B-type natriuretic peptide (BNP), effectively treats acute decompensated heart failure by improving hemodynamic function and clinical status. Early and outpatient use may reduce hospital stays and readmissions.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • B-type natriuretic peptide (BNP) is a cardiac neurohormone released in response to ventricular stretch.
  • Nesiritide is a recombinant form of human BNP used for heart failure treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of nesiritide in acute decompensated heart failure.
  • To explore potential future applications of nesiritide.

Main Methods:

  • Clinical trials involving administration of nesiritide infusions.
  • Assessment of hemodynamic parameters, clinical status, and hormonal levels.

Main Results:

  • Nesiritide decreased pulmonary capillary wedge pressure, pulmonary artery pressure, and systemic vascular resistance.

Related Experiment Videos

  • Increased cardiac index, stroke volume index, diuresis, and natriuresis were observed.
  • Patients reported improved clinical status, reduced dyspnea, and fatigue; hormonal levels and arrhythmias decreased.

    • Conclusions:

    • Nesiritide improves hemodynamic function and clinical outcomes in acute decompensated heart failure.
    • Early emergency department treatment and outpatient infusions show promise for reduced hospitalizations.
    • Potential applications include acute coronary syndromes, pulmonary hypertension, and as antifibrotic therapy.